ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia.

Eytan M Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.